Evaluation of effectiveness of the micrographia's therapy in Parkonson's disease patients;Ocena skuteczności leczenia mikrografii u chorych z choroba̧ Parkinsona

Polski Merkuriusz Lekarski

Volumn 20, Issue 120, 2006, Pages 688-690

  Jarzȩbska, Ewa ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Management; Micrographia; Parkinson's disease

Indexed keywords

LEVODOPA;

ADULT; AGED; ARTICLE; ATTENTION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE DURATION; EVALUATION; FEMALE; HUMAN; MAGNITUDE ESTIMATION METHOD; MALE; MICROSCOPY; PARKINSON DISEASE; SCORING SYSTEM; STATISTICAL ANALYSIS; SYMPTOM;

AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; PRACTICE (PSYCHOLOGY); PSYCHOMOTOR DISORDERS; TREATMENT OUTCOME;

EID: 33746112261     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Berardelli A., Rothwell C.J., Thompson P.D. i wsp.: Patophysiology of bradykinesia in Parkinson's disease. Brain, 2001, 124, 11, 2131-2146.
2. Burch D., Sheerin F.: Parkinson's disease. Lancet, 2005, 365, 9459, 622-625.
3. Byblow W.D., Lewis G.N., Stinear J.W.: Effector - specific visual information influences kinesthesis and reaction time performance in Parkinson's disease. J. Mot. Behav., 2003, 35, 2, 99-107.
4. Delwaide P.J., Pepin J.L., De Pasqua V. i wsp.: Projections from basal ganglia to tegmentum: a subcortical route for explaining the pathophysiology of Parkinson's disease signs? J. Neurol., 2000, 247, Suppl 2, 75-81.
5. Desmurget M., Grafton S.T., Vindras P. i wsp.: Basal ganglia network mediates the control of movement amplitude. Exp. Brain Res., 2003, 153, 2, 197-209.
6. Dubois B., Pillon B.: Cognitive deficits in Parkinson's disease. J. Neurol., 1997, 244, 1, 2-8.
7. Dujardin K., Degreef J.F., Rogelet P. i wsp.: Impairment of the supervisory attentional system in early untreated patients with Parkinson's disease. J. Neurol., 1999, 246, 9, 783-788.
8. Fahn S., Marsden C.D., Caine D.B., Goldstein M. (eds.): Recent developments in Parkinson's disease, vol 2., N.J. Macmillan Health Care Information, Florham Park, 1987, 153-163.
9. Jackson S.R., Jackson G.M., Harrison J. i wsp.: The internal control of action and Parkinson's disease: a kinematic analysis of visually-guided and memory-guided prehension movements. Exp. Brain Res., 1995, 105, 1, 147-162.
10. Lekwuwa G.U., Barnes G.R., Collins C.J.S. i wsp.: Progressive bradykinesia and hypokinesia of ocular pursuit in Parkinson's disease. J. Neurol. Neurosurg. Psychiatry, 1999, 66, 6, 746-753.
11. Morris M.E., Iansek R., Matyas T.A. i wsp.: The pathogenesis of gait hypokinesia in Parkinson's disease. Brain, 1994, 117, 5, 1169-1181.
12. Morris M.E.: Movement disorders in people with Parkinson disease: a model for physical therapy. Phys. Ther., 2000, 80, 6, 578-597.
13. Olanow W., Watts R.L., Koller W.C.: An algorithm (decision tree) for the management of Parkinson's disease (2001): treatment guideliness. Neurology, 2001, 56, Suppl 5, 1-88.
14. Oliveira R.M., Gurd J.M., Nixon P. i wsp.: Micrographia in Parkinson's disease: the effect of providing external cues. J. Neurol. Neurosurg. Psychiatry, 1997, 63, 4, 429-433.
15. Petit H., Allain H., Vermersch P.: Choroba Parkinsons. Klinika i leczenie. Sanmedia, Warszawa, 1997, 28-49.
16. Samii A., Nutt J.G., Ransom B.R.: Parkinson's disease. Lancet, 2004, 363, 9423, 1783-1793.
17. Stocchi F., Brusa L.: Cognition and emotion in different stages and subtypes of Parkinson's disease. J. Neurol., 2000, 247, Suppl 2, 114-121.
18. Tanji J., Shima K.: Supplementary motor cortex in organization of movement. Eur. Neurol., 1996, 36, suppl 1, 13-19.